Nifty
Sensex
:
:
25330.25
82693.71
91.15 (0.36%)
313.02 (0.38%)

Miscellaneous

Rating :
72/99

BSE: 506414 | NSE: Not Listed

351.10
17-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  350
  •  356.9
  •  348
  •  348.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  14151
  •  4974612
  •  356.9
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,033.32
  • 9.80
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,071.02
  • 0.71%
  • 2.67

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 64.09%
  • 1.87%
  • 29.60%
  • FII
  • DII
  • Others
  • 0.02%
  • 0.00%
  • 4.42%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.73
  • 4.47
  • 10.29

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.56
  • 6.00
  • 43.45

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 11.05
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.37
  • 18.43
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.73
  • 2.19
  • 2.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.36
  • 17.70
  • 21.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
136.26
78.13
74.40%
139.85
97.34
43.67%
156.47
98.97
58.10%
95.03
56.91
66.98%
Expenses
108.03
77.33
39.70%
102.90
91.97
11.88%
103.20
73.85
39.74%
76.25
70.83
7.65%
EBITDA
28.23
0.80
3,428.75%
36.94
5.37
587.90%
53.27
25.12
112.06%
18.78
-13.92
-
EBIDTM
20.72%
1.03%
26.42%
5.52%
34.04%
25.38%
19.76%
-24.46%
Other Income
8.77
2.82
210.99%
3.89
5.38
-27.70%
2.23
2.52
-11.51%
2.88
1.90
51.58%
Interest
3.10
3.43
-9.62%
2.99
3.39
-11.80%
4.08
5.19
-21.39%
3.69
3.69
0.00%
Depreciation
5.81
6.12
-5.07%
5.87
6.46
-9.13%
6.08
6.38
-4.70%
6.15
5.93
3.71%
PBT
28.09
-5.93
-
31.98
0.91
3,414.29%
45.34
16.07
182.14%
11.82
-29.06
-
Tax
6.48
0.00
0
-1.34
8.05
-
7.45
6.08
22.53%
0.70
0.00
0
PAT
21.60
-5.93
-
33.32
-7.15
-
37.89
9.99
279.28%
11.12
-29.06
-
PATM
15.85%
-7.59%
23.83%
-7.34%
24.21%
10.09%
11.70%
-51.07%
EPS
7.49
-2.01
-
11.79
-2.40
-
12.66
3.41
271.26%
3.92
-9.89
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
527.61
469.48
335.66
349.94
398.52
377.29
292.95
404.67
302.67
164.13
154.80
Net Sales Growth
59.23%
39.87%
-4.08%
-12.19%
5.63%
28.79%
-27.61%
33.70%
84.41%
6.03%
 
Cost Of Goods Sold
165.25
147.40
130.13
153.55
153.15
134.37
79.02
92.26
80.41
68.43
64.51
Gross Profit
362.36
322.08
205.52
196.39
245.36
242.92
213.92
312.42
222.26
95.70
90.29
GP Margin
68.68%
68.60%
61.23%
56.12%
61.57%
64.39%
73.02%
77.20%
73.43%
58.31%
58.33%
Total Expenditure
390.38
358.98
307.77
331.75
336.29
294.71
228.64
269.35
211.54
152.17
134.66
Power & Fuel Cost
-
27.23
19.78
18.24
20.35
14.23
12.74
13.88
11.11
9.97
8.67
% Of Sales
-
5.80%
5.89%
5.21%
5.11%
3.77%
4.35%
3.43%
3.67%
6.07%
5.60%
Employee Cost
-
65.10
58.55
58.00
62.97
58.22
50.03
53.18
39.83
30.84
27.97
% Of Sales
-
13.87%
17.44%
16.57%
15.80%
15.43%
17.08%
13.14%
13.16%
18.79%
18.07%
Manufacturing Exp.
-
46.62
36.56
32.66
37.22
31.08
21.62
27.60
26.64
17.04
12.03
% Of Sales
-
9.93%
10.89%
9.33%
9.34%
8.24%
7.38%
6.82%
8.80%
10.38%
7.77%
General & Admin Exp.
-
46.78
46.09
46.09
39.95
29.05
33.12
27.57
15.80
13.19
12.46
% Of Sales
-
9.96%
13.73%
13.17%
10.02%
7.70%
11.31%
6.81%
5.22%
8.04%
8.05%
Selling & Distn. Exp.
-
17.47
11.36
13.97
17.06
19.13
23.38
31.40
26.90
5.47
5.71
% Of Sales
-
3.72%
3.38%
3.99%
4.28%
5.07%
7.98%
7.76%
8.89%
3.33%
3.69%
Miscellaneous Exp.
-
8.37
5.30
9.24
5.58
8.63
8.73
23.47
10.84
7.23
5.71
% Of Sales
-
1.78%
1.58%
2.64%
1.40%
2.29%
2.98%
5.80%
3.58%
4.41%
2.13%
EBITDA
137.22
110.50
27.89
18.19
62.23
82.58
64.31
135.32
91.13
11.96
20.14
EBITDA Margin
26.01%
23.54%
8.31%
5.20%
15.62%
21.89%
21.95%
33.44%
30.11%
7.29%
13.01%
Other Income
17.77
11.82
11.81
8.60
8.25
8.37
14.20
26.50
10.83
2.78
1.31
Interest
13.86
14.89
17.43
21.37
17.98
19.00
20.09
21.23
13.63
9.96
6.15
Depreciation
23.91
24.22
24.72
28.25
25.56
20.31
15.00
11.89
12.36
10.31
8.35
PBT
117.23
83.21
-2.45
-22.83
26.94
51.63
43.42
128.71
75.97
-5.53
6.96
Tax
13.29
6.80
14.14
1.83
11.88
9.10
-16.10
10.80
21.13
2.70
4.25
Tax Rate
11.34%
8.17%
-143.12%
-3.57%
44.10%
17.63%
-37.08%
8.39%
27.81%
-48.82%
61.06%
PAT
103.93
76.86
-23.06
-51.07
15.45
45.51
59.53
117.88
42.21
-11.03
-0.59
PAT before Minority Interest
104.51
76.40
-24.01
-53.13
15.06
42.53
59.52
117.90
54.84
-8.23
2.71
Minority Interest
0.58
0.46
0.95
2.06
0.39
2.98
0.01
-0.02
-12.63
-2.80
-3.30
PAT Margin
19.70%
16.37%
-6.87%
-14.59%
3.88%
12.06%
20.32%
29.13%
13.95%
-6.72%
-0.38%
PAT Growth
423.27%
-
-
-
-66.05%
-23.55%
-49.50%
179.27%
-
-
 
EPS
35.35
26.14
-7.84
-17.37
5.26
15.48
20.25
40.10
14.36
-3.75
-0.20

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
362.67
288.86
315.31
372.13
360.59
309.44
250.55
124.45
144.40
129.82
Share Capital
14.58
14.44
14.43
14.42
14.42
14.42
4.59
2.29
2.29
2.29
Total Reserves
347.79
261.69
287.63
343.02
334.17
288.94
245.21
122.16
142.11
127.53
Non-Current Liabilities
29.24
77.03
97.43
154.05
131.41
71.52
125.39
145.65
48.11
24.27
Secured Loans
15.05
42.54
83.59
114.68
110.44
101.79
135.21
135.37
40.32
17.78
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
21.61
14.97
20.08
67.43
58.77
4.06
6.31
2.73
2.67
1.79
Current Liabilities
245.20
194.07
229.77
227.85
230.09
194.60
155.98
103.56
86.16
108.48
Trade Payables
77.49
64.90
45.79
64.58
62.14
56.33
42.72
40.09
27.49
19.77
Other Current Liabilities
47.84
39.61
58.53
43.72
49.90
33.12
47.42
29.38
20.79
56.62
Short Term Borrowings
81.24
67.34
101.46
97.47
96.30
104.33
60.21
29.86
37.13
29.34
Short Term Provisions
38.63
22.22
23.98
22.07
21.75
0.81
5.63
4.23
0.75
2.75
Total Liabilities
632.95
556.26
639.76
753.35
721.79
575.57
531.94
384.64
307.14
288.24
Net Block
223.37
263.13
238.25
231.31
262.93
128.89
103.73
96.88
89.81
168.10
Gross Block
367.61
387.06
338.52
308.92
330.73
166.48
128.99
114.18
103.03
221.97
Accumulated Depreciation
144.25
123.93
100.27
77.61
67.80
37.59
25.25
17.30
13.21
53.77
Non Current Assets
264.40
293.70
365.69
418.61
391.42
291.56
226.13
202.38
202.88
194.84
Capital Work in Progress
15.91
1.62
45.02
34.56
56.91
70.77
21.58
3.50
5.49
5.94
Non Current Investment
0.49
0.43
0.37
0.29
0.25
71.52
74.41
81.82
89.76
14.60
Long Term Loans & Adv.
19.36
21.05
29.33
81.35
70.47
19.60
18.64
6.80
4.51
6.20
Other Non Current Assets
2.10
2.07
24.01
3.82
0.86
0.78
7.77
13.39
13.31
0.01
Current Assets
368.55
262.57
274.07
334.74
330.38
284.01
295.61
182.27
104.26
93.40
Current Investments
0.00
0.00
2.78
0.00
0.00
0.00
1.15
1.06
1.00
0.80
Inventories
123.65
87.38
130.14
159.48
162.27
128.58
87.67
51.18
38.91
27.97
Sundry Debtors
95.23
69.83
41.65
87.09
68.01
69.77
65.54
68.72
44.57
43.01
Cash & Bank
71.70
59.83
58.33
33.61
44.53
33.11
91.13
32.66
2.49
4.79
Other Current Assets
77.98
6.55
4.08
11.25
55.56
52.55
50.12
28.65
17.28
16.84
Short Term Loans & Adv.
59.93
38.97
37.09
43.32
42.69
43.41
31.14
18.31
12.90
10.22
Net Current Assets
123.36
68.49
44.30
106.90
100.29
89.42
139.63
78.71
18.10
-15.08
Total Assets
632.95
556.27
639.76
753.35
721.80
575.57
531.93
384.65
307.14
288.24

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
40.90
105.35
116.11
43.44
62.60
34.46
90.34
59.26
1.91
4.44
PBT
83.21
-9.87
-51.31
26.94
51.63
43.42
128.71
75.97
-5.53
6.96
Adjustment
42.97
81.50
119.25
43.18
39.61
34.01
31.05
27.02
24.10
14.71
Changes in Working Capital
-82.50
32.70
44.95
-17.38
-15.12
-29.03
-36.56
-25.46
-14.42
-14.47
Cash after chg. in Working capital
43.67
104.33
112.90
52.75
76.12
48.40
123.20
77.54
4.16
7.21
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.77
1.02
3.21
-9.31
-13.52
-13.94
-32.86
-18.28
-2.25
-2.77
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-0.16
-15.50
-55.41
-26.04
-41.55
-43.66
-96.58
-101.14
6.52
-13.38
Net Fixed Assets
5.15
-13.76
-37.00
43.97
-138.56
-83.89
-136.01
-3.33
90.14
-15.75
Net Investments
-0.06
11.72
-2.36
-0.04
58.91
3.87
116.82
-76.31
-75.58
-0.61
Others
-5.25
-13.46
-16.05
-69.97
38.10
36.36
-77.39
-21.50
-8.04
2.98
Cash from Financing Activity
-50.87
-90.85
-41.38
-21.58
-1.14
-47.45
12.22
88.82
-12.11
10.42
Net Cash Inflow / Outflow
-10.12
-1.00
19.32
-4.17
19.90
-56.65
5.99
46.93
-3.67
1.48
Opening Cash & Equivalents
16.75
17.75
-1.61
2.29
-18.22
38.42
32.44
-14.50
-10.82
3.30
Closing Cash & Equivalent
6.63
16.75
17.75
-1.88
2.29
-18.22
38.42
32.44
-14.50
4.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
124.23
95.63
104.67
123.91
120.84
105.16
87.07
45.22
52.47
47.18
ROA
12.85%
-4.01%
-7.63%
2.04%
6.56%
10.75%
25.73%
15.85%
-2.76%
0.99%
ROE
23.93%
-8.30%
-16.11%
4.27%
13.05%
21.92%
64.77%
40.79%
-6.00%
2.08%
ROCE
21.97%
1.58%
-5.25%
7.50%
12.62%
12.98%
40.16%
33.86%
1.96%
6.18%
Fixed Asset Turnover
1.24
0.93
1.08
1.25
1.52
1.98
3.33
2.79
1.02
0.87
Receivable days
64.16
60.61
67.14
71.03
66.65
84.30
60.55
68.24
96.46
90.86
Inventory Days
82.04
118.27
151.04
147.34
140.69
134.72
62.62
54.27
73.67
57.38
Payable days
176.30
155.24
131.18
150.99
160.90
86.23
63.57
60.55
60.91
51.44
Cash Conversion Cycle
-30.10
23.64
87.00
67.38
46.44
132.79
59.60
61.95
109.22
96.80
Total Debt/Equity
0.30
0.48
0.72
0.66
0.66
0.73
0.87
1.39
0.60
0.70
Interest Cover
6.59
0.43
-1.40
2.50
3.72
3.16
7.06
6.57
0.45
2.13

News Update:


  • Fermenta Biotech - Quarterly Results
    12th Aug 2025, 13:06 PM

    Read More
  • Fermenta Biotech secures CEP from EDQM for Vitadee 100 SD
    30th Jul 2025, 11:42 AM

    Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin?D3

    Read More
  • Fermenta Biotech enters into strategic MoU with NIFTEM-T
    11th Jul 2025, 18:01 PM

    The company will provide technical expertise and infrastructure support to NIFTEM-T’s Centre of Excellence for Food Fortification

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.